Global Epinephrine Market Growth 2023-2029

Global Epinephrine Market Growth 2023-2029

Product Code:457626

Published Date: Feb 08,2023

Pages: 103

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.

As a medication it is used to treat a number of conditions, including anaphylaxis, cardiac arrest, and superficial bleeding. In this report, we mainly focus on the Epinephrine Auto-injector and Epinephrine Prefilled Syringe.

LPI (LP Information)' newest research report, the “Epinephrine Industry Forecast” looks at past sales and reviews total world Epinephrine sales in 2022, providing a comprehensive analysis by region and market sector of projected Epinephrine sales for 2023 through 2029. With Epinephrine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Epinephrine industry.

This Insight Report provides a comprehensive analysis of the global Epinephrine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Epinephrine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Epinephrine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Epinephrine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Epinephrine.

The global Epinephrine market size is projected to grow from US$ 2970.9 million in 2022 to US$ 4885.9 million in 2029; it is expected to grow at a CAGR of 4885.9 from 2023 to 2029.

Global Epinephrine key players include Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, etc. Global top five manufacturers hold a share about 60%. USA is the largest market, with a share about 40%, followed by Europe, with a share about 35 percent. In terms of product, Epinephrine Auto-injector is the largest segment, with a share about 60%. And in terms of application, the largest application is Anaphylaxis, followed by Cardiac Arrest, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Epinephrine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Epinephrine Auto-injector
    Epinephrine Prefilled Syringe
    Combination Epinephrine Products

Segmentation by application
    Anaphylaxis
    Cardiac Arrest
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Mylan Inc
    Impax
    ALK Abello
    Lincoln Medical
    Pfizer
    Amphastar
    Emerade
    Grand Pharma
    Harvest Pharmaceuticals
    Merit Pharmaceutical
    Tianjin Jinyao

Key Questions Addressed in this Report
What is the 10-year outlook for the global Epinephrine market?
What factors are driving Epinephrine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Epinephrine market opportunities vary by end market size?
How does Epinephrine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?